See also this year's filing and all EDGAR filings for this company.
PDF Report 0001517681_2018_Propanc_Biopharma_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001517681')"} |
Graph
Absolute values for 0001517681, Propanc Biopharma Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 81,976 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 10,790 |
3 | remainder_Assets | 2,303 |
4 | LiabilitiesCurrent | 5,536,820 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 4,739,431 |
9 | ResearchAndDevelopmentExpense | 971,769 |
10 | remainder_Expenses | -276,681 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | -2,432,981 |
13 | remainder_ComprehensiveNetIncome | -273,013 |
yvar | yval | |
---|---|---|
0 | Assets | 95,069 |
1 | Liabilities | 5,536,820 |
2 | Expenses | 5,434,519 |
3 | Revenues | 0 |
4 | StockholdersEquity | -5,441,751 |
5 | NetIncome | -7,867,500 |
6 | ComprehensiveNetIncome | -8,004,006 |
7 | BaseVar | 6,886,201 |
8 | EconomicCapitalRatio | -6.17 |